231 related articles for article (PubMed ID: 27846627)
41. Improvement of atopic dermatitis-like skin lesions by Platycodon grandiflorum fermented by Lactobacillus plantarum in NC/Nga mice.
Kim MS; Kim WG; Chung HS; Park BW; Ahn KS; Kim JJ; Bae H
Biol Pharm Bull; 2012; 35(8):1222-9. PubMed ID: 22863917
[TBL] [Abstract][Full Text] [Related]
42. Drug evaluation review: dupilumab in atopic dermatitis.
Hamilton JD; Ungar B; Guttman-Yassky E
Immunotherapy; 2015; 7(10):1043-58. PubMed ID: 26598956
[TBL] [Abstract][Full Text] [Related]
43. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.
Yang G; Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326002
[TBL] [Abstract][Full Text] [Related]
44. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
45. Advances in atopic dermatitis in 2015.
Nomura T; Kabashima K
J Allergy Clin Immunol; 2016 Dec; 138(6):1548-1555. PubMed ID: 27931536
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic Effects of Korean Red Ginseng Extract in a Murine Model of Atopic Dermatitis: Anti-pruritic and Anti-inflammatory Mechanism.
Lee HJ; Cho SH
J Korean Med Sci; 2017 Apr; 32(4):679-687. PubMed ID: 28244297
[TBL] [Abstract][Full Text] [Related]
47. IL-13 antagonists in the treatment of atopic dermatitis.
Tubau C; Puig L
Immunotherapy; 2021 Mar; 13(4):327-344. PubMed ID: 33430628
[TBL] [Abstract][Full Text] [Related]
48. IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.
Floudas A; Saunders SP; Moran T; Schwartz C; Hams E; Fitzgerald DC; Johnston JA; Ogg GS; McKenzie AN; Walsh PT; Fallon PG
J Immunol; 2017 Jul; 199(2):707-717. PubMed ID: 28615416
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of SHANK-associated RH domain-interacting protein elevates interleukin-33 expression by stimulating the Janus kinase 2/signal transducer and activator of transcription signalling pathway in HaCaT cells.
Zhang X; Wang J; Zhu J; Liang Y
Clin Exp Dermatol; 2021 Jul; 46(5):880-887. PubMed ID: 33548083
[TBL] [Abstract][Full Text] [Related]
50. Bee Venom Phospholipase A2 Ameliorates House Dust Mite Extract Induced Atopic Dermatitis Like Skin Lesions in Mice.
Jung KH; Baek H; Kang M; Kim N; Lee SY; Bae H
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218721
[TBL] [Abstract][Full Text] [Related]
51. Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis.
Gaffal E; Glodde N; Jakobs M; Bald T; Tüting T
Exp Dermatol; 2014 Jun; 23(6):401-6. PubMed ID: 24750433
[TBL] [Abstract][Full Text] [Related]
52. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin.
Yoo J; Omori M; Gyarmati D; Zhou B; Aye T; Brewer A; Comeau MR; Campbell DJ; Ziegler SF
J Exp Med; 2005 Aug; 202(4):541-9. PubMed ID: 16103410
[TBL] [Abstract][Full Text] [Related]
53. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.
Elias PM; Schmuth M
Curr Allergy Asthma Rep; 2009 Jul; 9(4):265-72. PubMed ID: 19656472
[TBL] [Abstract][Full Text] [Related]
54. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu.
Niebuhr M; Baumert K; Heratizadeh A; Satzger I; Werfel T
Allergy; 2014 Aug; 69(8):1058-67. PubMed ID: 24894535
[TBL] [Abstract][Full Text] [Related]
55. Keratinocytes in atopic dermatitis express abundant ΔNp73 regulating thymic stromal lymphopoietin production via NF-κB.
Kumagai A; Kubo T; Kawata K; Kamekura R; Yamashita K; Jitsukawa S; Nagaya T; Sumikawa Y; Himi T; Yamashita T; Ichimiya S
J Dermatol Sci; 2017 Nov; 88(2):175-183. PubMed ID: 28655470
[TBL] [Abstract][Full Text] [Related]
56. Periostin promotes chronic allergic inflammation in response to Th2 cytokines.
Masuoka M; Shiraishi H; Ohta S; Suzuki S; Arima K; Aoki S; Toda S; Inagaki N; Kurihara Y; Hayashida S; Takeuchi S; Koike K; Ono J; Noshiro H; Furue M; Conway SJ; Narisawa Y; Izuhara K
J Clin Invest; 2012 Jul; 122(7):2590-600. PubMed ID: 22684102
[TBL] [Abstract][Full Text] [Related]
57. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents.
Danso MO; van Drongelen V; Mulder A; van Esch J; Scott H; van Smeden J; El Ghalbzouri A; Bouwstra JA
J Invest Dermatol; 2014 Jul; 134(7):1941-1950. PubMed ID: 24518171
[TBL] [Abstract][Full Text] [Related]
58. Dupilumab for Moderate-to-Severe Atopic Dermatitis.
Vangipuram R; Tyring SK
Skin Therapy Lett; 2017 Nov; 22(6):1-4. PubMed ID: 29091379
[TBL] [Abstract][Full Text] [Related]
59. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
Brunner PM; Pavel AB; Khattri S; Leonard A; Malik K; Rose S; Jim On S; Vekaria AS; Traidl-Hoffmann C; Singer GK; Baum D; Gilleaudeau P; Sullivan-Whalen M; Fuentes-Duculan J; Li X; Zheng X; Estrada Y; Garcet S; Wen HC; Gonzalez J; Coats I; Cueto I; Neumann AU; Lebwohl MG; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jan; 143(1):142-154. PubMed ID: 30121291
[TBL] [Abstract][Full Text] [Related]
60.
Oh JS; Lee SJ; Choung SY
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
